Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mihoko Matsumura"'
Autor:
Yuki Nakatani, Tsuyoshi Monden, Minoru Sato, Nozomi Domeki, Mihoko Matsumura, Nobuyuki Banba, Takaaki Nakamoto
Publikováno v:
Case Reports in Endocrinology, Vol 2012 (2012)
We report a 32-year-old Japanese women with severe hypoglycemia accompanied with thyroid crisis. She complained of dyspnea, general fatigue, and leg edema. She was diagnosed with hyperthyroidism with congestive heart failure and liver dysfunction. So
Externí odkaz:
https://doaj.org/article/0ceafdfa96bc42ce9358861ab0255f58
Autor:
Shunichi Murano, Nobuya Fujita, Ken Tomotsune, Minoru Sato, Hisamoto Kuroda, Yasuko Chiba, Yoshihisa Takada, Mihoko Matsumura, Teruo Jojima, Yoshimasa Aso, Isao Usui
Publikováno v:
International Journal of Clinical Practice. 75
AIM We compared the efficacy and safety of insulin degludec/insulin aspart co-formulation (IDegAsp) twice-daily to a free combination of basal insulin degludec and GLP-1 receptor agonist liraglutide (IDeg + Lira) once-daily for patients with inadequa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22fa908e412df581c1cf8b94d814feb6
https://doi.org/10.1111/ijcp.13734
https://doi.org/10.1111/ijcp.13734
Autor:
Nobuya Fujita, Yasuko Chiba, Teruo Jojima, Yoshihisa Takada, Hisamoto Kuroda, Shunichi Murano, Ken Tomotsune, Mihoko Matsumura, Yoshimasa Aso, Minoru Sato, Isao Usui
Aim: We compared the efficacy and safety of insulin degludec/insulin aspart co-formulation (IDegAsp) twice-daily to a free combination of basal insulin degludec and GLP-1 receptor agonist liraglutide (IDeg+Lira) once-daily for patients with inadequat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad0041fad598cfc95e406e7c7cd5bdd1
https://doi.org/10.22541/au.159129005.57065700
https://doi.org/10.22541/au.159129005.57065700
Autor:
Atsuhiko Kawabe, Shoya Ono, Takanori Yasu, Nobuyuki Banba, Yasushi Miyashita, Yuki Nakatani, Mihoko Matsumura
Publikováno v:
Diabetes. 69
Introduction and Hypothesis: White blood cell (WBC) count in healthy persons is reported to be associated with the risk of coronary artery disease (CAD) and all-cause death. The aim of our study was to determine whether WBC count predicts cardiovascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e224778d1720ad059d0869cfe22c498e
https://doi.org/10.2337/db20-1425-p
https://doi.org/10.2337/db20-1425-p
Autor:
Nobuyuki Banba, Takanori Yasu, Yuki Nakatani, Atsuhiko Kawabe, Mihoko Matsumura, Yasushi Miyashita, Shoya Ono, Yoshimasa Aso
Publikováno v:
Diabetes. 69
Introduction: Hemorheology (blood viscosity) was reported to be a strong predictor of cardiovascular events in the Edinburgh Artery Study. However, deterioration in hemorheology through microvessels is a potential adverse effect of Sodium-glucose cot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14e4630e2b58219f9b8e1713b9bcf2cc
https://doi.org/10.2337/db20-1106-p
https://doi.org/10.2337/db20-1106-p
Autor:
Yuki Nakatani, Mihoko Matsumura, Nobuyuki Banba, M. Maeda, Takanori Yasu, H. Harasawa, Riha Shimizu, Yoshimasa Aso
Publikováno v:
Diabetes & Metabolism. 43:430-437
This study evaluated the effects of a glucagon-like peptide-1 receptor agonist on gastrointestinal (GI) tract motility and residue rates by examining GI transit time and lumen using capsule endoscopy.GI motility and lumen were assessed by capsule end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6eeb2ccd106dfe8d6429ceeab82565
https://doi.org/10.1016/j.diabet.2017.05.009
https://doi.org/10.1016/j.diabet.2017.05.009
Autor:
Yuki Nakatani, Masaaki Sagara, Mihoko Matsumura, Chie Aoki, Seiichi Tanka, Kazunori Yanagi, Kunihiro Suzuki, Yoshimasa Aso
Publikováno v:
Diabetes Therapy
Introduction The efficacy of administering a sodium–glucose cotransporter 2 inhibitor during insulin therapy has not been established. In this study, we examined its effects based on diurnal glycemic patterns using continuous glucose monitoring (CG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0867b8b243302b1c44a01214fcb32c9c
http://europepmc.org/articles/PMC5544611
http://europepmc.org/articles/PMC5544611
Autor:
Nozomi, Domeki, Tsuyoshi, Monden, Mihoko, Matsumura, Hiroaki, Shimizu, Shiori, Ikeda, Atsuko, Sukegawa, Kazunori, Yanagi, Chie, Aoki, Yoshiaki, Kawahoe, Hiroyuki, Kase, Kikuo, Kasai
Publikováno v:
Dokkyo journal of medical sciences. 37(3):181-186
日本甲状腺学会から甲状腺クリーゼの診断基準が2008 年に発表された.2004 年4 月から2009 年3月に当院で臨床的に甲状腺クリーゼと診断,治療した20 症例を,その診断基準にあてはめ,治療と予
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::70df4a5b383ca9a1000617195dba3669
http://id.nii.ac.jp/1199/00000892/
http://id.nii.ac.jp/1199/00000892/
Autor:
Takanori Yasu, Atsuhiko Kawabe, Yoshimasa Aso, Nobuyuki Banba, Takaaki Nakamoto, Yuki Nakatani, Mihoko Matsumura
Publikováno v:
Diabetes Care. 39:e22-e23
Long- and short-acting glucagon-like peptide 1 receptor agonists (GLP-1RAs) liraglutide and lixisenatide, which are available for diabetes therapy, may act on the autonomic nervous system to increase heart rate (1,2). We performed a prospective, sing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70f3f05da51855e21182f4aed34b0960
https://doi.org/10.2337/dc15-1437
https://doi.org/10.2337/dc15-1437
Autor:
Mihoko Matsumura, Yuki Nakatani, Seiichi Tanka, Chie Aoki, Masaaki Sagara, Kazunori Yanagi, Kunihiro Suzuki, Yoshimasa Aso
Publikováno v:
Diabetes Therapy. 8:1437-1437
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78fc334d6784b44b0c63b22b1fd94c8e
https://doi.org/10.1007/s13300-017-0308-x
https://doi.org/10.1007/s13300-017-0308-x